Avadel Pharmaceuticals Under Investigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 19 2025
0mins
Source: DEFA14A
Halper Sadeh LLC is investigating Avadel Pharmaceuticals PLC for potential violations of federal securities laws and breaches of fiduciary duties. This investigation may impact shareholder confidence and stock performance.
The firm encourages shareholders to contact them to discuss their rights, indicating that there may be limited time to enforce these rights. This legal scrutiny comes at a time when the stock has hit a 5-day low, reflecting investor concerns.
As the broader market shows gains, with the Nasdaq-100 up 1.15% and the S&P 500 up 0.96%, Avadel's decline highlights specific issues affecting the company rather than general market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
